钙网蛋白(CALR)活性蛋白
Active Calreticulin (CALR)
CRT; RO; SSA; CC1qR; ERp60; HACBP; grp60; CRTC; CRP55; Calregulin; Sicca Syndrome Antigen A; Autoantigen Ro; Endoplasmic reticulum resident protein 60
- 编号APB486Hu61
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 97%
- 等电点4.3
- 应用Cell culture; Activity Assays.
- 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1814 ¥ 4536 ¥ 9072 ¥ 27216 ¥ 68040
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
活性实验
Calreticulin (CALR) is an endoplasmic reticulum (ER)-resident protein involved in a spectrum of cellular processes. In healthy cells, CALR operates as a chaperone and Ca2 buffer to assist correct protein folding within the ER. Calreticulin is also found in the nucleus, suggesting that it may have a role in transcription regulation. Systemic lupus erythematosus is associated with increased autoantibody titers against calreticulin. Recurrent mutations in calreticulin have been linked to various neoplasms, including the myeloproliferative type. Adhesive glycoprotein THBS1 has been shown to play roles in platelet aggregation, angiogenesis and tumorigenesis, the protein is an interactor of CALR, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human CALR and recombinant rat THBS1. Briefly, biotin-linked CALR were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to THBS1-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µl stop solution to the wells and read at 450 nm immediately. The binding activity of CALR andTHBS1 was shown in Figure 1, the EC50 for this effect is 0.018 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
APB486Hu61 | 钙网蛋白(CALR)活性蛋白 | Cell culture; Activity Assays. |
EPB486Hu61 | 钙网蛋白(CALR)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB486Hu03 | 钙网蛋白(CALR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB486Hu02 | 钙网蛋白(CALR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB486Hu01 | 钙网蛋白(CALR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPB486Hu21 | 钙网蛋白(CALR)卵白蛋白偶联物 | Immunogen; SDS-PAGE; WB. |
PAB486Hu02 | 钙网蛋白(CALR)多克隆抗体 | WB; IHC; ICC; IP; FCM |
PAB486Hu01 | 钙网蛋白(CALR)多克隆抗体 | WB; IHC; ICC; IP; FCM |
PAB486Hu08 | 钙网蛋白(CALR)多克隆抗体 | WB; IHC; ICC; IP. |
LAB486Hu71 | 钙网蛋白(CALR)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAB486Hu22 | 钙网蛋白(CALR)单克隆抗体 | WB; IHC; ICC; IP. |
SEB486Hu | 钙网蛋白(CALR)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
CEB486Hu | 钙网蛋白(CALR)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB486Hu | 钙网蛋白(CALR)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
KSB486Hu01 | 钙网蛋白(CALR)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
杂志 | 参考文献 |
Journal of Investigative Dermatology | Oxidative Stress-Induced Calreticulin Expression and Translocation: New Insights into the Destruction of Melanocytes [Pubmed: 23771121] |
International Journal of Molecular Sciences | The Anticoagulant Effect of PGI2S and tPA in Transgenic Umbilical Vein Endothelial Cells Is Linked to Up-Regulation of PKA and PKC [Mdpi: Source] |
The Journal of Maternal-Fetal & Neonatal Medicine | Amniotic fluid calreticulin in pregnancies complicated by the preterm prelabor rupture of membranes [Pubmed:26953684] |
journal of maternal-fetal & neonatal medicine | Cervical fluid calreticulin and cathepsin-G in pregnancies complicated by preterm prelabor rupture of membranes. [pubmed:28152632] |
Talanta | Investigation of the interaction between calreticulin and immunoglobulin G by capillary electrophoresis and computer modeling [Doi: 10.1016/j.talanta.2018.11.098] |
Sci Adv | Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia [Pubmed:35171673] |